Literature DB >> 11216980

A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.

K Piippo1, H Swan, M Pasternack, H Chapman, K Paavonen, M Viitasalo, L Toivonen, K Kontula.   

Abstract

OBJECTIVES: We took advantage of the genetic isolate of Finns to characterize a common long QT syndrome (LQTS) mutation, and to estimate the prevalence of LQTS.
BACKGROUND: The LQTS is caused by mutations in different ion channel genes, which vary in their molecular nature from family to family.
METHODS: The potassium channel gene KCNQ1 was sequenced in two unrelated Finnish patients with Jervell and Lange-Nielsen syndrome (JLNS), followed by genotyping of 114 LQTS probands and their available family members. The functional properties of the mutation were studied using a whole-cell patch-damp technique.
RESULTS: We identified a novel missense mutation (G589D or KCNQ1-Fin) in the C-terminus of the KCNQ1 subunit. The voltage threshold of activation for the KCNQ1-Fin channel was markedly increased compared to the wild-type channel. This mutation was present in homozygous form in two siblings with JLNS, and in heterozygous form in 34 of 114 probands with Romano-Ward syndrome (RWS) and 282 family members. The mean (+/- SD) rate-corrected QT intervals of the heterozygous subjects (n = 316) and noncarriers (n = 423) were 460 +/- 40 ms and 410 +/- 20 ms (p < 0.001), respectively.
CONCLUSIONS: A single missense mutation of the KCNQ1 gene accounts for 30% of Finnish cases with LQTS, and it may be associated with both the RWS and JLNS phenotypes of the syndrome. The relative enrichment of this mutation most likely represents a founder gene effect. These circumstances provide an excellent opportunity to examine how genetic and nongenetic factors modify the LQTS phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11216980     DOI: 10.1016/s0735-1097(00)01124-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

1.  More light on QT interval measurement.

Authors:  L Toivonen
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 2.  Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.

Authors:  Michael J Ackerman; Peter J Mohler
Journal:  Circ Res       Date:  2010-08-20       Impact factor: 17.367

Review 3.  Computational biology in the study of cardiac ion channels and cell electrophysiology.

Authors:  Yoram Rudy; Jonathan R Silva
Journal:  Q Rev Biophys       Date:  2006-07-19       Impact factor: 5.318

Review 4.  Novel mutations of KCNQ1 in Long QT syndrome.

Authors:  Sameera F Qureshi; Altaf Ali; Venkateshwari Ananthapur; M P Jayakrishnan; Narasimhan Calambur; Kumarasamy Thangaraj; Pratibha Nallari
Journal:  Indian Heart J       Date:  2013-09-04

5.  LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.

Authors:  Ademuyiwa S Aromolaran; Prakash Subramanyam; Donald D Chang; William R Kobertz; Henry M Colecraft
Journal:  Cardiovasc Res       Date:  2014-10-24       Impact factor: 10.787

Review 6.  Gene variants predisposing to SIDS: current knowledge.

Authors:  Siri H Opdal; Torleiv O Rognum
Journal:  Forensic Sci Med Pathol       Date:  2010-07-11       Impact factor: 2.007

7.  Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population.

Authors:  Annukka M Lahtinen; Aki S Havulinna; Peter A Noseworthy; Antti Jula; Pekka J Karhunen; Markus Perola; Christopher Newton-Cheh; Veikko Salomaa; Kimmo Kontula
Journal:  Ann Med       Date:  2013-05-08       Impact factor: 4.709

Review 8.  Pharmacogenetic issues in thorough QT trials.

Authors:  Richard S Judson; Benjamin A Salisbury; Carol R Reed; Michael J Ackerman
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 9.  Beyond membrane channelopathies: alternative mechanisms underlying complex human disease.

Authors:  Konstantinos Dean Boudoulas; Peter J Mohler
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

10.  Mutation of an A-kinase-anchoring protein causes long-QT syndrome.

Authors:  Lei Chen; Michelle L Marquardt; David J Tester; Kevin J Sampson; Michael J Ackerman; Robert S Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.